Literature DB >> 9439645

Early-appearing tumor-infiltrating natural killer cells play an important role in the nitric oxide production of tumor-associated macrophages through their interferon production.

K Abe1, M Harada, K Tamada, O Ito, T Li, K Nomoto.   

Abstract

Both natural killer (NK) cells and macrophages are thought to be the main effectors responsible for early antitumor defense. In this study, we investigated the role of tumor-infiltrating NK cells in initiating nitric oxide (NO) production by tumor-associated macrophages (TAM). The in vivo depletion of NK cells prior to the i.p. inoculation of melanoma cells resulted in a significant decrease in the NO production of the TAM prepared from the peritoneal exudate cells (PEC). Such prior NK cell depletion also decreased the ability of TAM to show any antitumor activity in vitro. The addition of NG-monomethyl-L-arginine (Me-L-Arg) to the culture partially inhibited the ability of TAM to suppress the proliferation of melanoma cells and also decreased their cytolytic activity against melanoma cells. These results suggest that the TAM exhibited both cytostatic and cytolytic activities through their NO production. In an in vivo assay, the administration of Me-L-Arg permitted the more rapid growth of i.p. inoculated melanoma cells compared with the control. On the other hand, the decreased NO production of TAM, resulting from the prior NK cell depletion, was restored by the i.p. administration of interferon gamma (IFN gamma). In addition, the in vivo administration of anti-IFN gamma mAb into mice inoculated i.p. with melanoma cells also significantly decreased the NO production of TAM in peritoneal exudate cells. Furthermore, the tumor-infiltrating NK cells produced a considerable level of IFN gamma. Overall, these results indicate that early-appearing tumor-infiltrating NK cells play an important role in the NO production of TAM through their IFN gamma production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9439645     DOI: 10.1007/s002620050437

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  7 in total

1.  Inhibition of B16 melanoma experimental metastasis by interferon-gamma through direct inhibition of cell proliferation and activation of antitumour host mechanisms.

Authors:  Shigeru Kakuta; Yoh-ichi Tagawa; Shinwa Shibata; Masanobu Nanno; Yoichiro Iwakura
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

2.  Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity.

Authors:  N Seo; S Hayakawa; M Takigawa; Y Tokura
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

3.  Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection.

Authors:  Yi-Wei Li; Shuang-Jian Qiu; Jia Fan; Qiang Gao; Jian Zhou; Yong-Sheng Xiao; Yang Xu; Xiao-Ying Wang; Jian Sun; Xiao-Wu Huang
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-10       Impact factor: 4.553

4.  Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition.

Authors:  Li Yang; MingJing Shen; Li Jun Xu; Xiaodong Yang; Ying Tsai; Peter C Keng; Yuhchyau Chen; Soo Ok Lee
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

5.  Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving Immunotherapy.

Authors:  Saurabh K Garg; Matthew J Ott; A G M Mostofa; Zhihua Chen; Y Ann Chen; Jodi Kroeger; Biwei Cao; Adam W Mailloux; Alisha Agrawal; Braydon J Schaible; Amod Sarnaik; Jeffrey S Weber; Anders E Berglund; James J Mulé; Joseph Markowitz
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

6.  What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.

Authors:  Andrea Palicelli; Stefania Croci; Alessandra Bisagni; Eleonora Zanetti; Dario De Biase; Beatrice Melli; Francesca Sanguedolce; Moira Ragazzi; Magda Zanelli; Alcides Chaux; Sofia Cañete-Portillo; Maria Paola Bonasoni; Alessandra Soriano; Stefano Ascani; Maurizio Zizzo; Carolina Castro Ruiz; Antonio De Leo; Guido Giordano; Matteo Landriscina; Giuseppe Carrieri; Luigi Cormio; Daniel M Berney; Jatin Gandhi; Valerio Copelli; Giuditta Bernardelli; Giacomo Santandrea; Martina Bonacini
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

7.  Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.

Authors:  LiJun Xu; XiaoDong Chen; MingJing Shen; Dong-Rong Yang; Laifu Fang; Guobin Weng; Ying Tsai; Peter C Keng; Yuhchyau Chen; Soo Ok Lee
Journal:  Mol Oncol       Date:  2018-01-24       Impact factor: 6.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.